Anti-fibrotic effect of wogonin in renal tubular epithelial cells via Smad3-dependent mechanisms

Eur J Pharmacol. 2016 Oct 15:789:134-143. doi: 10.1016/j.ejphar.2016.07.014. Epub 2016 Jul 8.

Abstract

Renal fibrosis, a common feature and leading cause for End Stage Renal Disease, still lacks effective therapy. In the current study, we detected and compared the anti-fibrotic effects of wogonin and wogonoside, two major components of Scutellaria baicalensis Georgi, in TGF-β1-treated tubular epithelial cells of human and murine origins. Results consistently showed that compared with wogonoside, wogonin inhibits TGF-β1-induced upregulated mRNA and protein levels of collagen I and α-SMA with more efficiency, which was further confirmed by the immunofluorescence results that wogonin decreased the percentage of collagen I and α-SMA positive cells in TGF-β1-treated tubular epithelial cells. Mechanistically, wogonin mainly decreased Smad3 phosphorylation, but had marginal effect on non-canonical TGF-β signaling pathways, such as p38 and ERK MAP Kinase. Furthermore, in the cells deficient for TGF-β signaling or downstream Smad3, results demonstrated that even high concentration of wogonin failed to further decrease the level of collagen I and α-SMA, indicating the essential role of TGF-β/Smad3 signaling inhibition in the therapeutic action of wogonin in TGF-β1-stimulated tubular epithelial cells. Collectively, our results indicated that wogonin may be utilized as a potential anti-fibrotic Traditional Chinese Medicine monomer in the treatment of renal fibrosis.

Keywords: Renal fibrosis; Smad3; TGF-β1; Wogonin.

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Animals
  • Cell Line
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Dose-Response Relationship, Drug
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology*
  • Fibrosis
  • Flavanones / pharmacology*
  • Flavanones / therapeutic use
  • Glucosides / pharmacology*
  • Glucosides / therapeutic use
  • Humans
  • Kidney Tubules, Proximal / pathology*
  • Mice
  • Phosphorylation / drug effects
  • Rats
  • Receptors, Transforming Growth Factor beta / deficiency
  • Receptors, Transforming Growth Factor beta / metabolism
  • Smad3 Protein / deficiency
  • Smad3 Protein / metabolism*
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • Flavanones
  • Glucosides
  • Receptors, Transforming Growth Factor beta
  • Smad3 Protein
  • Transforming Growth Factor beta1
  • wogonoside